Phreesia, Inc. (NYSE:PHR) Shares Sold by Blair William & Co. IL

Blair William & Co. IL trimmed its position in Phreesia, Inc. (NYSE:PHR) by 78.6% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 145,450 shares of the company’s stock after selling 534,524 shares during the period. Blair William & Co. IL owned 0.25% of Phreesia worth $3,660,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Nicholas Company Inc. acquired a new position in shares of Phreesia in the 4th quarter worth approximately $2,452,000. State Street Corp boosted its holdings in Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after purchasing an additional 88,517 shares during the period. JPMorgan Chase & Co. increased its stake in Phreesia by 144.2% during the fourth quarter. JPMorgan Chase & Co. now owns 145,716 shares of the company’s stock valued at $3,666,000 after purchasing an additional 86,040 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Phreesia by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 4,823,110 shares of the company’s stock worth $121,349,000 after purchasing an additional 61,048 shares during the period. Finally, Geode Capital Management LLC lifted its position in shares of Phreesia by 4.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock worth $28,397,000 after buying an additional 55,934 shares during the last quarter. 92.10% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on PHR. KeyCorp increased their price objective on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and raised their price target for the stock from $24.00 to $32.00 in a report on Wednesday, January 8th. Truist Financial boosted their price objective on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. Finally, Robert W. Baird reduced their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $31.33.

Phreesia Trading Down 1.6 %

Shares of NYSE:PHR opened at $25.57 on Tuesday. The company has a 50 day moving average of $27.35 and a 200-day moving average of $24.20. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The firm has a market cap of $1.50 billion, a P/E ratio of -17.40 and a beta of 1.03. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $30.53.

Insider Buying and Selling

In other Phreesia news, COO Evan Roberts sold 2,873 shares of the business’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $26.61, for a total value of $76,450.53. Following the sale, the chief operating officer now directly owns 779,993 shares in the company, valued at approximately $20,755,613.73. The trade was a 0.37 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Allison C. Hoffman sold 3,496 shares of the firm’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $25.32, for a total transaction of $88,518.72. Following the transaction, the general counsel now owns 139,134 shares of the company’s stock, valued at approximately $3,522,872.88. This trade represents a 2.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 164,269 shares of company stock valued at $4,661,469 over the last quarter. Corporate insiders own 5.80% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.